Bank of Nova Scotia’s Achaogen Inc AKAO Stock Holding History

Bank of Nova Scotia’s Portfolio AKAO Stock Details AKAO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-50,000	Closed	-$23K	–	867
2019 Q1	$23K	Hold	50,000	–	–	﹤0.01%	835
2018 Q4	$62K	Buy	50,000 +45,000	+900%	+$120K	﹤0.01%	837
2018 Q3	$200K	Buy	+5,000	New	+$30.2K	﹤0.01%	847
2017 Q3	–	Sell	-80,061	Closed	-$1.74M	–	1020
2017 Q2	$1.74M	Buy	+80,061	New	+$1.83M	0.01%	661

Other funds holding AKAO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Bank of Nova Scotia's AKAO Position: Q2 2019 in Review

Bank of Nova Scotia sold out of Achaogen Inc (AKAO) in Q2 2019, closing a stake of 50,000 shares — an estimated $23K sold.

Bank of Nova Scotia first reported a position in AKAO in Q2 2017 and held it in 4 quarters. The position peaked at $1.74M in Q2 2017. 8 funds tracked by Wall St. Rank hold AKAO as of Q2 2019.

Bank of Nova Scotia reported no remaining Achaogen Inc position as of Q2 2019 after selling out during the quarter.
Bank of Nova Scotia sold 50,000 Achaogen Inc shares in Q2 2019, an estimated $23K.
Bank of Nova Scotia first reported a position in Achaogen Inc in Q2 2017 and held it in 4 quarters.
Bank of Nova Scotia's Achaogen Inc position peaked at $1.74M in Q2 2017.
8 funds tracked by Wall St. Rank held Achaogen Inc as of Q2 2019.

Based on Bank of Nova Scotia's 13F filing for Q2 2019, filed 13 Aug 2019.